Effect of Ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats

International Journal of Molecular Sciences

Volumn 12, Issue 3, 2011, Pages 1991-2006

  Zengyong, Qiao ^a   Jiangwei, Ma ^a   Huajin, Liu ^a  

^a Fengxian Branch of Shanghai Sixth People's Hospital   (China)

Author keywords

Antioxidant; Immunity; Ischemic reperfusion injury; Ligusticum wallichii extract

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CATALASE; CREATINE KINASE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; LIGUSTICUM WALLICHII EXTRACT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; OXIDOREDUCTASE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SCREENING; HEART MUSCLE ISCHEMIA; IMMUNE RESPONSE; LIGUSTICUM; LIGUSTICUM WALLICHII; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HEART; HEART MUSCLE; IMMUNOLOGY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; WISTAR RAT;

LIGUSTICUM; LIGUSTICUM WALLICHII; RATTUS;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HEART; LIGUSTICUM; MALE; MALONDIALDEHYDE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; OXIDOREDUCTASES; PLANT EXTRACTS; RATS; RATS, WISTAR; WATER;

EID: 79953324374     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12031991     Document Type: Article

References (54)

1. Li, S.Z. Bencao Gangmu (Compendium of Materia Medica). JiLin University Publishing House: ChangChun, China, 2009.
2. Chiou, G.C.Y.; Yan, H.Y.; Lei, H.Y.; Li, B.H.P.; Shen, Z.F. Ocular and cardiovascular pharmacology of tetramethylpyrazine isolated from Ligusticum wallichii Franch. Zhong Guo Yao Li Xue Bao 1991, 12, 99-104.
3. Hwang, K.C. The Pharmacology of Chinese Herb; CRC Press: Boca Raton, FL, USA, 1993; p. 84.
4. Hansen, P.R. Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur. Heart J. 1995, 16, 734-740.
5. McCord, J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 1985, 312, 159-163.
6. Kloner, R.A.; Przyklenk, K.; Whittaker, P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989, 80, 1115-1126.
7. Thompson-Gorman S.L.; Zweier, J.L. Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J. Biol. Chem. 1990, 265, 6656-6663.
8. Ruuge, E.K.; Ledenev, A.N.; Lakomkin, V.L.; Konstantinov, A.A.; Ksenzenko, M.Y. Free radical metabolites in myocardium during ischemia-reperfusion. Am. J. Physiol. 1991, 261, 81-86.
9. Takemura, G.; Onodera, T.; Ashraf, M. Quantification of hydroxyl radical and its lack of relevance to myocardial injury during early reperfusion after graded ischemia in rat hearts. Circ. Res. 1992, 71, 96-105.
10. Downey, J.M.; Omar, B.; Ooiwa, H.; McCord, J. Inferoxide dismutase therapy for myocardial ischemia. Free Radic. Res. Commun. 1991, 12, 703-720.
11. Qiu, Y.; Galinanes, M.; Ferrari, R.; Cargnoni, A.; Ezrin, A.; Hearse, D.J. PEG-SOD improves postischemic functional recovery and antioxidant status in blood-perfused rabbit hearts. Am. J. Physiol. 1992, 263, H1243-H1249.
12. Haramaki, N.; Packer, L.; Assadnazari, H.; Zimmer, G. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem. Biophys. Res. Commun. 1993, 196, 1101-1107.
13. Sies, H. Oxidative stress: from basic research to clinical application. Am. J. Med. 1991, 91, 31S-38S.
14. Poltronieri, R.; Cevese, A.; Sbarbati, A. Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience 1992, 3, 155-160.
15. Gross, G.J.; Farber, N.E.; Hardman, H.F.; Warltier, D.C. Beneficial actions of inferoxide dismutase and catalase in stunned myocardium of dogs. Am. J. Physiol. 1986, 250, 372-377.
16. Opie, L.H. Reperfusion injury and its pharmacologic modification. Circulation 1989, 80, 1049-1062.
17. Kloner, R.A.; Przyklenk, K.; Whittaker, P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989, 80, 1115-1127
18. Kilgore, K.S.; Lucchesi, B.R. Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. Clin. Biochem. 1993, 26, 359-370.
19. Godin, D.V.; Garnett, M.E. Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol. Can. J. Cardiol. 1989, 5, 365-371.
20. Pyles, L.A.; Fortney, J.E.; Kudlak, J.J.; Gustafson, R.A.; Einzig, S. Plasma antioxidant depletion after cardiopulmonary bypass in operations for congenital heart disease. J. Thorac. Cardiovasc. Surg. 1995, 110, 165-171.
21. Ko, K.M.; Garnett, M.E.; Godin, D.V. Altered antioxidant status in ischemic/reperfused rabbit myocardium: reperfusion time-course study. Can. J. Cardiol. 1990, 6, 299-304.
22. Leichtweis, S.; Ji, L.L. Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiol. Scand. 2001, 172, 1-10.
23. Fan, T.M.; Kranz, D.M.; Flavell, R.A.; Roy, E.J. Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells. Mol. Immunol. 2008, 45, 2937-2950.
24. Lakoski, S.G.; Liu, Y.; Brosnihan, K.B.; Herrington, D.M. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study. Atherosclerosis 2008, 197, 443-447.
25. Eefting, D.; Schepers, A.; de Vries, M.R.; Pires, N.M.; Grimbergen, J.M.; Lagerweij, T.; Nagelkerken, L.M.; Monraats, P.S.; Jukema, J.W.; van Bockel, J.H.; Quax, P.H. The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice. Atherosclerosis 2007, 193, 335-342.
26. Satterthwaite, G.; Francis, S.E.; Suvarna, K.; Blakemore, S.; Ward, C.; Wallace, D.; Braddock, M.; Crossman, D. Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis. Am. Heart J. 2005, 150, 488-499.
27. de Waal Malefyt, R.; Abrams, J.; Bennett, B.; Figdor, C.G.; de Vries, J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991, 174, 1209-1220.
28. Moro, C.; Jouan, M.G.; Rakotovao, A.; Toufektsian, M.C.; Ormezzano, O.; Nagy, N.; Tosaki, A.; de Leiris, J.; Boucher, F. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3014-H3019.
29. Cheng, X.S.; Shimokawa, H.; Momii, H.; Oyama, J.; Fukuyama, N.; Egashira, K.; Nakazawa, H.; Takeshita, A. Role of inferoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc. Res. 1999, 42, 651-659.
30. Hotta, Y.; Otsuka-Murakami, H.; Fujita, M.; Nakagawa, J.; Yajima, M.; Liu, W.; Ishikawa, N.; Kawai, N.; Masumizu, T.; Kohno, M. 1999. Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria. Eur. J. Pharmacol. 1999, 380, 37-48.
31. Michel, T.; Feron, O. Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 1997, 100, 2146-2152.
32. Forstermann, U.; Pollock, J.S.; Schmidt, H.H.; Heller, M.; Murad, F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 1991, 88, 1788-1792.
33. Hughes, B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin. Chim. Acta 1962, 7, 597-604.
34. Wroblewski, F.; Cabaud, P.G. Colorimetric measurement of lactic dehydro-genase activity of body fluids. Am. J. Clin. Pathol. 1958, 30, 234.
35. Durak, I.; Kavutcu, M.; Kaçmaz, M.; Avci, A.; Horasanli, E.; Dikmen, B. Effects of isoflurane on nitric oxide metabolism and oxidant status of rat myocardium. Acta Anaesthesiol. Scand. 2001, 45, 119-122.
36. Buege, A.; Aust, S. Microsomal lipid peroxidation. Methods Enzymol. 1978, 51, 302-307.
37. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.
38. Sun, Y.; Oberley, L.W.; Li, Y. A simple method for clinical assay of inferoxide dismutase. Clin. Chem. 1988, 34, 497-500.
39. Aebi, H.E. Catalase in vitro. Methods Enzymol. 1984, 105, 121-126.
40. Flohe, L.; Gunzler A.W. Analysis of glutathione peroxidase. Methods Enzymol. 1984, 105, 114-121.
41. Benzie, I.F.F.; Stain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of -antioxidant power{norm of matrix}, the FRAP assay. Anal. Biochem. 1996, 239, 70-76.
42. Tsakiris, S.; Deliconstantinos, G. Influence of phosphatidylserine on (Na++K+)-stimulated ATPase and acetylcholonesterase activities of dog brain synaptossomal plasma membranes. Biochem. J. 1984, 22, 301-307.
43. 2+-stimulated ATPase activity. Anal. Biochem. 1986, 157, 375-380.
44. Bayer, A.J.; Chadha, J.S.; Farag, R.R.; Pathy, M.S.J. Changing presentation of myocardial infarction with increasing old age. J. Am. Geriatr. Soc. 1986, 34, 263-266.
45. Mathew, S.; Menon, P.V.; Kurup, P.A. Effect of administration of vitamin A, ascorbic acid and nicotinamide adenine dinucleotide and flavine adenine nucleotide on severity of myocardial infarction induced by isoproterenol in rats. Indian J. Exp. Biol. 1985, 23, 500-504.
46. Gurevitch, J.; Frolkis, I.; Yuhas, Y.; Lifschitz-Mercer, B.; Berger, E.; Paz, Y.; Matsa, M.; Kramer, A.; Mohr, R. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J. Am. Coll. Cardiol. 1997, 30, 1554-1561.
47. Heemann, U.; Szabo, A.; Hamar, P.; Müller, V.; Witzke, O.; Lutz, J.; Philipp, T. Lipopolysaccharide pre-treatment protects from renal ischemia/reperfusion injury. Am. J. Pathol. 2000, 156, 287-293.
48. Deamen, M.; van de Ven, M.; Heineman, E.; Buurman, W. Involvement of endogenous interleukin-10 and tumor necrosis factor-α in renal ischemia-reperfusion injury. Transplantation 1999, 67, 792-800.
49. Meng, G.L.; Zhu, H.Y.; Yang, S.J.; Wu, F.; Zheng, H.H.; Chen, E.; Xu, J.L. Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohydr. Polym. 2011, 84, 180-185.
50. Laursen, B.E.; Stankevicius, E.; Pilegaard, H.; Mulvany, M.; Simonsen, U. Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung. Cardiovasc. Drug Rev. 2006, 24, 247-260.
51. Reichenbach, G.; Momi, S.; Gresele, P. Nitric oxide and its antithrombotic action in the cardiovascular system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5, 65-74.
52. +-ATPase activity and force of contraction in rat heart. Biochem. Pharmacol. 1980, 29, 3219-3129.
53. Jaeschke, H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. 2003, 284, G15-G26.
54. Fondevila, C.; Busuttil, R.W.; Kupiec-Weglinski, J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp. Mol. Pathol. 2003, 74, 86-93.